We first helped friends, family and colleagues to understand what it was like to live with Crohn’s or Colitis. Now we want everyone to understand.
We’ve teamed up with pharmaceutical company Takeda UK to create this innovative app which allows anyone to step into the life of someone living with Crohn’s or Colitis for a day.
From depleting energy levels to managing pain, from rushing to the toilet to juggling work and a social life, the app allows friends, family and anyone you want, to see first-hand how the condition can affect every part of your body, and every aspect of your life.
Don’t worry - after 24 hours they can return to their normal lives. But they’ll do so with a deeper understanding and appreciation of what you have to go through every day.
We want to help people better understand what it’s like to live with Crohn’s or Colitis and empower you to have conversations with people in your lives.
Through the national launch of this digital tool we aim to break down stigma, reduce isolation and encourage people to think of ways they can support friends, family and colleagues living with Crohn’s or Colitis.
My mum has always been a huge support to me. She’s helped so much from when I was diagnosed with a small baby and throughout – coping with Colitis and having two young children. In completing the In My Shoes app she has been able to experience what it is like for me on a day to day basis and we have been able to have a much more straightforward conversation about things like going to the loo. It’s taken any awkwardness away from the situation and I feel she has a much better feeling for what it is like to have Colitis
"Understanding what people with Crohn's and Colitis go through is so important to improve the lives of everybody living with these debilitating conditions," said Sarah Sleet, CEO of Crohn’s & Colitis UK. "The In My Shoes App sparks conversations that soon lead to practical things we can all do to help. Even small gestures can go a long way, if you feel you are no longer alone when facing these conditions.”
This programme was developed with and partially funded by pharmaceutical company Takeda UK, one of Crohn’s & Colitis UK’s corporate partners.